Report Scope & Overview:
Cannabis Use Disorder Treatment Market size was valued at US$ 1.57 Billion in 2022 to US$ 2.66 Billion by 2033, exhibiting a CAGR of 4.9% From 2023-2033
Cannabis Use Disorder Treatment Market Overview:
Global Cannabis Use Disorder Treatment Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. Cannabis Use Disorder Treatment Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
Overall, Cannabis Use Disorder Treatment market plays a crucial role in helping businesses and organizations make informed decisions based on data-driven insights. As the demand for data-driven decision-making continues to grow, Cannabis Use Disorder Treatment market research is expected to experience further growth and innovation in the coming years.
Global Cannabis Use Disorder Treatment Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. Cannabis Use Disorder Treatment Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
Overall, Cannabis Use Disorder Treatment market plays a crucial role in helping businesses and organizations make informed decisions based on data-driven insights. As the demand for data-driven decision-making continues to grow, Cannabis Use Disorder Treatment market research is expected to experience further growth and innovation in the coming years.
DESCIMG1
Cannabis Use Disorder Treatment Market Key Trends
Behavioral Therapies: Evidence-based behavioral therapies, such as cognitive-behavioral therapy (CBT) and contingency management, continued to be primary treatment modalities for CUD, helping individuals change their patterns of cannabis use.
Pharmacotherapy Research: Ongoing research into pharmacotherapies to treat CUD, including medications that target the endocannabinoid system or help manage withdrawal symptoms, such as nabiximols (Sativex), naltrexone, and others.
Motivational Enhancement Therapy (MET): MET gained popularity as an approach to enhance individuals' motivation to engage in CUD treatment and make behavioral changes.
Telehealth and Digital Therapeutics: The COVID-19 pandemic accelerated the adoption of telehealth and digital therapeutic tools for CUD treatment, making therapy and support more accessible.
Integrated Care Models: Treatment centers increasingly adopted integrated care models that address not only CUD but also underlying mental health issues and comorbid conditions.
Stigma Reduction: Efforts were made to reduce the stigma associated with seeking CUD treatment, encouraging individuals to seek help without fear of judgment.
Youth-Specific Interventions: With the rising prevalence of CUD among youth, the development of youth-specific interventions and prevention programs became more prominent.
Peer Support and Recovery Coaching: The incorporation of peer support and recovery coaching programs to provide individuals with personal, lived-experience guidance and encouragement in their recovery journey.
Market Segmentations:Global Cannabis Use Disorder Treatment Market: By Company
• AbbVie
• Alkermes
• BioCorRx
• Cipla Limited
• Dr. Reddy’s Laboratories
• Glenmark Pharmaceuticals Limited
• Intas Pharmaceuticals Limited
• Indivior
• Mallinckrodt
• Noramco
• Orexo AB
• Purdue Pharma
Global Cannabis Use Disorder Treatment Market: By Type
• Tobacco/Nicotine and Vaping
• Alcohol
• Marijuana
• Synthetic Cannabinoids
• Others
Global Cannabis Use Disorder Treatment Market: By Application
• Hospitals and Clinics
• Rehabilitation Centers
• Others
Global Cannabis Use Disorder Treatment Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Cannabis Use Disorder Treatment market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
| Report Attribute/Metric | Details |
| Market Size 2022 | US$ 1.57 Billion |
| Market Size 2033 | US$ 2.66 Billion |
| Compound Annual Growth Rate (CAGR) | 4.9%(2023-2033) |
| Base Year | 2022 |
| Forecast Period | 2023-2032 |
| Historical Data | 2018-2022 |
| Forecast Units | Value (US$ Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| By Type | • Tobacco/Nicotine and Vaping • Alcohol • Marijuana • Synthetic Cannabinoids • Others |
| By Application | • Hospitals and Clinics • Rehabilitation Centers |
| Key Companies Profiled | • AbbVie • Alkermes • BioCorRx • Cipla Limited • Dr. Reddy’s Laboratories • Glenmark Pharmaceuticals Limited • Intas Pharmaceuticals Limited • Indivior • Mallinckrodt • Noramco • Orexo AB • Purdue Pharma |
| Regions and Key Countries Covered | U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America |
| Customization Scope | Available on Request |
Reasons to Purchase Cannabis Use Disorder Treatment Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Objectives of Cannabis Use Disorder Treatment Market Study:
The objectives of Cannabis Use Disorder Treatment market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Cannabis Use Disorder Treatment market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Frequently Asked Questions
Cannabis Use Disorder Treatment Market size was valued at US$ 1.57 Billion in 2022 to US$ 2.66 Billion by 2033, exhibiting a CAGR of 4.9% From 2023-2033
Primary interventions include behavioral therapies, pharmacotherapies, motivational enhancement therapy, and integrated care models.
The pandemic accelerated the adoption of telehealth and digital therapeutic tools, making treatment more accessible.
Emerging trends focus on providing targeted interventions and support for youth facing CUD challenges.
Efforts are made to reduce the stigma associated with seeking CUD treatment to encourage individuals to seek help without judgment.
TABLE OF CONTENT
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cannabis Use Disorder Treatment Market Size Growth Rate by Type: 2017 VS 2022 VS 2032
1.2.2 Tobacco/Nicotine and Vaping
1.2.3 Alcohol
1.2.4 Marijuana
1.2.5 Synthetic Cannabinoids
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cannabis Use Disorder Treatment Market Growth by Application: 2017 VS 2022 VS 2032
1.3.2 Hospitals and Clinics
1.3.3 Rehabilitation Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cannabis Use Disorder Treatment Market Perspective (2017-2032)
2.2 Cannabis Use Disorder Treatment Growth Trends by Region
2.2.1 Global Cannabis Use Disorder Treatment Market Size by Region: 2017 VS 2022 VS 2032
2.2.2 Cannabis Use Disorder Treatment Historic Market Size by Region (2017-2023)
2.2.3 Cannabis Use Disorder Treatment Forecasted Market Size by Region (2023-2032)
2.3 Cannabis Use Disorder Treatment Market Dynamics
2.3.1 Cannabis Use Disorder Treatment Industry Trends
2.3.2 Cannabis Use Disorder Treatment Market Drivers
2.3.3 Cannabis Use Disorder Treatment Market Challenges
2.3.4 Cannabis Use Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cannabis Use Disorder Treatment Players by Revenue
3.1.1 Global Top Cannabis Use Disorder Treatment Players by Revenue (2017-2023)
3.1.2 Global Cannabis Use Disorder Treatment Revenue Market Share by Players (2017-2023)
3.2 Global Cannabis Use Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cannabis Use Disorder Treatment Revenue
3.4 Global Cannabis Use Disorder Treatment Market Concentration Ratio
3.4.1 Global Cannabis Use Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cannabis Use Disorder Treatment Revenue in 2022
3.5 Cannabis Use Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Cannabis Use Disorder Treatment Product Solution and Service
3.7 Date of Enter into Cannabis Use Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cannabis Use Disorder Treatment Breakdown Data by Type
4.1 Global Cannabis Use Disorder Treatment Historic Market Size by Type (2017-2023)
4.2 Global Cannabis Use Disorder Treatment Forecasted Market Size by Type (2023-2032)
5 Cannabis Use Disorder Treatment Breakdown Data by Application
5.1 Global Cannabis Use Disorder Treatment Historic Market Size by Application (2017-2023)
5.2 Global Cannabis Use Disorder Treatment Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Cannabis Use Disorder Treatment Market Size (2017-2032)
6.2 North America Cannabis Use Disorder Treatment Market Growth Rate by Country: 2017 VS 2022 VS 2032
6.3 North America Cannabis Use Disorder Treatment Market Size by Country (2017-2023)
6.4 North America Cannabis Use Disorder Treatment Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cannabis Use Disorder Treatment Market Size (2017-2032)
7.2 Europe Cannabis Use Disorder Treatment Market Growth Rate by Country: 2017 VS 2022 VS 2032
7.3 Europe Cannabis Use Disorder Treatment Market Size by Country (2017-2023)
7.4 Europe Cannabis Use Disorder Treatment Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cannabis Use Disorder Treatment Market Size (2017-2032)
8.2 Asia-Pacific Cannabis Use Disorder Treatment Market Growth Rate by Region: 2017 VS 2022 VS 2032
8.3 Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region (2017-2023)
8.4 Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cannabis Use Disorder Treatment Market Size (2017-2032)
9.2 Latin America Cannabis Use Disorder Treatment Market Growth Rate by Country: 2017 VS 2022 VS 2032
9.3 Latin America Cannabis Use Disorder Treatment Market Size by Country (2017-2023)
9.4 Latin America Cannabis Use Disorder Treatment Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cannabis Use Disorder Treatment Market Size (2017-2032)
10.2 Middle East & Africa Cannabis Use Disorder Treatment Market Growth Rate by Country: 2017 VS 2022 VS 2032
10.3 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country (2017-2023)
10.4 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Cannabis Use Disorder Treatment Introduction
11.1.4 AbbVie Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.1.5 AbbVie Recent Development
11.2 Alkermes
11.2.1 Alkermes Company Detail
11.2.2 Alkermes Business Overview
11.2.3 Alkermes Cannabis Use Disorder Treatment Introduction
11.2.4 Alkermes Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.2.5 Alkermes Recent Development
11.3 BioCorRx
11.3.1 BioCorRx Company Detail
11.3.2 BioCorRx Business Overview
11.3.3 BioCorRx Cannabis Use Disorder Treatment Introduction
11.3.4 BioCorRx Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.3.5 BioCorRx Recent Development
11.4 Cipla Limited
11.4.1 Cipla Limited Company Detail
11.4.2 Cipla Limited Business Overview
11.4.3 Cipla Limited Cannabis Use Disorder Treatment Introduction
11.4.4 Cipla Limited Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.4.5 Cipla Limited Recent Development
11.5 Dr. Reddy’s Laboratories
11.5.1 Dr. Reddy’s Laboratories Company Detail
11.5.2 Dr. Reddy’s Laboratories Business Overview
11.5.3 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Introduction
11.5.4 Dr. Reddy’s Laboratories Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.5.5 Dr. Reddy’s Laboratories Recent Development
11.6 Glenmark Pharmaceuticals Limited
11.6.1 Glenmark Pharmaceuticals Limited Company Detail
11.6.2 Glenmark Pharmaceuticals Limited Business Overview
11.6.3 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Introduction
11.6.4 Glenmark Pharmaceuticals Limited Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.6.5 Glenmark Pharmaceuticals Limited Recent Development
11.7 Intas Pharmaceuticals Limited
11.7.1 Intas Pharmaceuticals Limited Company Detail
11.7.2 Intas Pharmaceuticals Limited Business Overview
11.7.3 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Introduction
11.7.4 Intas Pharmaceuticals Limited Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.7.5 Intas Pharmaceuticals Limited Recent Development
11.8 Indivior
11.8.1 Indivior Company Detail
11.8.2 Indivior Business Overview
11.8.3 Indivior Cannabis Use Disorder Treatment Introduction
11.8.4 Indivior Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.8.5 Indivior Recent Development
11.9 Mallinckrodt
11.9.1 Mallinckrodt Company Detail
11.9.2 Mallinckrodt Business Overview
11.9.3 Mallinckrodt Cannabis Use Disorder Treatment Introduction
11.9.4 Mallinckrodt Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.9.5 Mallinckrodt Recent Development
11.10 Noramco
11.10.1 Noramco Company Detail
11.10.2 Noramco Business Overview
11.10.3 Noramco Cannabis Use Disorder Treatment Introduction
11.10.4 Noramco Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.10.5 Noramco Recent Development
11.11 Orexo AB
11.11.1 Orexo AB Company Detail
11.11.2 Orexo AB Business Overview
11.11.3 Orexo AB Cannabis Use Disorder Treatment Introduction
11.11.4 Orexo AB Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.11.5 Orexo AB Recent Development
11.12 Purdue Pharma
11.12.1 Purdue Pharma Company Detail
11.12.2 Purdue Pharma Business Overview
11.12.3 Purdue Pharma Cannabis Use Disorder Treatment Introduction
11.12.4 Purdue Pharma Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.12.5 Purdue Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cannabis Use Disorder Treatment Market Size Growth Rate by Type: 2017 VS 2022 VS 2032
1.2.2 Tobacco/Nicotine and Vaping
1.2.3 Alcohol
1.2.4 Marijuana
1.2.5 Synthetic Cannabinoids
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cannabis Use Disorder Treatment Market Growth by Application: 2017 VS 2022 VS 2032
1.3.2 Hospitals and Clinics
1.3.3 Rehabilitation Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cannabis Use Disorder Treatment Market Perspective (2017-2032)
2.2 Cannabis Use Disorder Treatment Growth Trends by Region
2.2.1 Global Cannabis Use Disorder Treatment Market Size by Region: 2017 VS 2022 VS 2032
2.2.2 Cannabis Use Disorder Treatment Historic Market Size by Region (2017-2023)
2.2.3 Cannabis Use Disorder Treatment Forecasted Market Size by Region (2023-2032)
2.3 Cannabis Use Disorder Treatment Market Dynamics
2.3.1 Cannabis Use Disorder Treatment Industry Trends
2.3.2 Cannabis Use Disorder Treatment Market Drivers
2.3.3 Cannabis Use Disorder Treatment Market Challenges
2.3.4 Cannabis Use Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cannabis Use Disorder Treatment Players by Revenue
3.1.1 Global Top Cannabis Use Disorder Treatment Players by Revenue (2017-2023)
3.1.2 Global Cannabis Use Disorder Treatment Revenue Market Share by Players (2017-2023)
3.2 Global Cannabis Use Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cannabis Use Disorder Treatment Revenue
3.4 Global Cannabis Use Disorder Treatment Market Concentration Ratio
3.4.1 Global Cannabis Use Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cannabis Use Disorder Treatment Revenue in 2022
3.5 Cannabis Use Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Cannabis Use Disorder Treatment Product Solution and Service
3.7 Date of Enter into Cannabis Use Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cannabis Use Disorder Treatment Breakdown Data by Type
4.1 Global Cannabis Use Disorder Treatment Historic Market Size by Type (2017-2023)
4.2 Global Cannabis Use Disorder Treatment Forecasted Market Size by Type (2023-2032)
5 Cannabis Use Disorder Treatment Breakdown Data by Application
5.1 Global Cannabis Use Disorder Treatment Historic Market Size by Application (2017-2023)
5.2 Global Cannabis Use Disorder Treatment Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Cannabis Use Disorder Treatment Market Size (2017-2032)
6.2 North America Cannabis Use Disorder Treatment Market Growth Rate by Country: 2017 VS 2022 VS 2032
6.3 North America Cannabis Use Disorder Treatment Market Size by Country (2017-2023)
6.4 North America Cannabis Use Disorder Treatment Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cannabis Use Disorder Treatment Market Size (2017-2032)
7.2 Europe Cannabis Use Disorder Treatment Market Growth Rate by Country: 2017 VS 2022 VS 2032
7.3 Europe Cannabis Use Disorder Treatment Market Size by Country (2017-2023)
7.4 Europe Cannabis Use Disorder Treatment Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cannabis Use Disorder Treatment Market Size (2017-2032)
8.2 Asia-Pacific Cannabis Use Disorder Treatment Market Growth Rate by Region: 2017 VS 2022 VS 2032
8.3 Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region (2017-2023)
8.4 Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cannabis Use Disorder Treatment Market Size (2017-2032)
9.2 Latin America Cannabis Use Disorder Treatment Market Growth Rate by Country: 2017 VS 2022 VS 2032
9.3 Latin America Cannabis Use Disorder Treatment Market Size by Country (2017-2023)
9.4 Latin America Cannabis Use Disorder Treatment Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cannabis Use Disorder Treatment Market Size (2017-2032)
10.2 Middle East & Africa Cannabis Use Disorder Treatment Market Growth Rate by Country: 2017 VS 2022 VS 2032
10.3 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country (2017-2023)
10.4 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Cannabis Use Disorder Treatment Introduction
11.1.4 AbbVie Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.1.5 AbbVie Recent Development
11.2 Alkermes
11.2.1 Alkermes Company Detail
11.2.2 Alkermes Business Overview
11.2.3 Alkermes Cannabis Use Disorder Treatment Introduction
11.2.4 Alkermes Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.2.5 Alkermes Recent Development
11.3 BioCorRx
11.3.1 BioCorRx Company Detail
11.3.2 BioCorRx Business Overview
11.3.3 BioCorRx Cannabis Use Disorder Treatment Introduction
11.3.4 BioCorRx Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.3.5 BioCorRx Recent Development
11.4 Cipla Limited
11.4.1 Cipla Limited Company Detail
11.4.2 Cipla Limited Business Overview
11.4.3 Cipla Limited Cannabis Use Disorder Treatment Introduction
11.4.4 Cipla Limited Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.4.5 Cipla Limited Recent Development
11.5 Dr. Reddy’s Laboratories
11.5.1 Dr. Reddy’s Laboratories Company Detail
11.5.2 Dr. Reddy’s Laboratories Business Overview
11.5.3 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Introduction
11.5.4 Dr. Reddy’s Laboratories Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.5.5 Dr. Reddy’s Laboratories Recent Development
11.6 Glenmark Pharmaceuticals Limited
11.6.1 Glenmark Pharmaceuticals Limited Company Detail
11.6.2 Glenmark Pharmaceuticals Limited Business Overview
11.6.3 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Introduction
11.6.4 Glenmark Pharmaceuticals Limited Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.6.5 Glenmark Pharmaceuticals Limited Recent Development
11.7 Intas Pharmaceuticals Limited
11.7.1 Intas Pharmaceuticals Limited Company Detail
11.7.2 Intas Pharmaceuticals Limited Business Overview
11.7.3 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Introduction
11.7.4 Intas Pharmaceuticals Limited Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.7.5 Intas Pharmaceuticals Limited Recent Development
11.8 Indivior
11.8.1 Indivior Company Detail
11.8.2 Indivior Business Overview
11.8.3 Indivior Cannabis Use Disorder Treatment Introduction
11.8.4 Indivior Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.8.5 Indivior Recent Development
11.9 Mallinckrodt
11.9.1 Mallinckrodt Company Detail
11.9.2 Mallinckrodt Business Overview
11.9.3 Mallinckrodt Cannabis Use Disorder Treatment Introduction
11.9.4 Mallinckrodt Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.9.5 Mallinckrodt Recent Development
11.10 Noramco
11.10.1 Noramco Company Detail
11.10.2 Noramco Business Overview
11.10.3 Noramco Cannabis Use Disorder Treatment Introduction
11.10.4 Noramco Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.10.5 Noramco Recent Development
11.11 Orexo AB
11.11.1 Orexo AB Company Detail
11.11.2 Orexo AB Business Overview
11.11.3 Orexo AB Cannabis Use Disorder Treatment Introduction
11.11.4 Orexo AB Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.11.5 Orexo AB Recent Development
11.12 Purdue Pharma
11.12.1 Purdue Pharma Company Detail
11.12.2 Purdue Pharma Business Overview
11.12.3 Purdue Pharma Cannabis Use Disorder Treatment Introduction
11.12.4 Purdue Pharma Revenue in Cannabis Use Disorder Treatment Business (2017-2023)
11.12.5 Purdue Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
AbbVie
Alkermes
BioCorRx
Cipla Limited
Dr. Reddy’s Laboratories
Glenmark Pharmaceuticals Limited
Intas Pharmaceuticals Limited
Indivior
Mallinckrodt
Noramco
Orexo AB
Purdue Pharma
In Vitro Diagnostics Quality Control Market
Global In Vitro Diagnostics Quality Control Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Ileostomy Market
Global Ileostomy Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market
Global Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Human Papillomavirus Vaccine Market
Global Human Papillomavirus Vaccine Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hospital Acquired Pneumonia Drugs Market
Global Hospital Acquired Pneumonia Drugs Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast